Cancer is a heterogeneous disease with numerous subtypes, each responding differently to various treatments. As new therapies such as targeted therapies and immunotherapies emerge, the need to compare these options against traditional methods like chemotherapy and radiation therapy becomes critical. CER helps clinicians and patients make informed decisions by providing evidence on the relative benefits and harms of different interventions.
